IL-21R inhibitors belong to a chemical class of compounds designed to specifically target and modulate the activity of the Interleukin-21 Receptor (IL-21R). The IL-21R is a cell surface receptor found on various immune cells, and it plays a pivotal role in regulating immune responses. When the cytokine IL-21 binds to IL-21R, it initiates a complex signaling cascade that influences immune cell development, differentiation, and function. The chemical structure of IL-21R inhibitors is engineered to interact with the IL-21R's binding site, obstructing the binding of IL-21 to the receptor. By doing so, these inhibitors disrupt the transmission of cellular signals that would normally occur upon IL-21 binding. This interference can modulate various immune processes and affect the behavior of immune cells.
IL-21R inhibitors can take several forms, such as small molecules, monoclonal antibodies, or other biologic agents. Their design involves intricate molecular engineering and extensive research to ensure specificity in targeting IL-21R and efficacy in blocking its signaling pathway without inducing significant off-target effects.The development of IL-21R inhibitors is a subject of ongoing research in the field of immunology. As scientists continue to explore the molecular mechanisms underlying immune responses, these inhibitors play a crucial role in elucidating the specific roles of IL-21R in the immune system. The chemical class of IL-21R inhibitors holds promise as valuable tools for advancing our understanding of immune regulation.
VOIR ÉGALEMENT...
| Nom du produit | CAS # | Ref. Catalogue | Quantité | Prix HT | CITATIONS | Classement |
|---|---|---|---|---|---|---|
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $246.00 $490.00 $536.00 | 16 | |
Un autre inhibiteur de JAK, qui peut empêcher l'activation des protéines STAT qui serait normalement déclenchée par la signalisation de l'IL-21. | ||||||
Baricitinib | 1187594-09-7 | sc-364730 sc-364730A | 5 mg 25 mg | $196.00 $651.00 | ||
Inhibiteur de JAK1 et JAK2, bloquant potentiellement plusieurs points de la cascade de signalisation de l'IL-21. | ||||||
TG101348 | 936091-26-8 | sc-364740 sc-364740A | 5 mg 25 mg | $207.00 $515.00 | 6 | |
Inhibe JAK2, qui est impliqué dans la voie de signalisation de nombreuses cytokines, y compris l'IL-21. | ||||||
GSK2126458 | 1086062-66-9 | sc-364503 sc-364503A | 2 mg 10 mg | $260.00 $1029.00 | ||
Un inhibiteur de JAK1, qui aurait un impact sur la signalisation en aval du récepteur de l'IL-21. | ||||||
Filgotinib | 1206161-97-8 | sc-507393 | 10 mg | $150.00 | ||
Inhibe sélectivement JAK1, ce qui pourrait perturber la signalisation médiée par l'IL-21. | ||||||